Cognitive appraisal and life stress moderate the effects of the 5-HTTLPR polymorphism on amygdala reactivity.
The short allele of the serotonin-transporter-linked promoter region (5-HTTLPR) polymorphism is associated with increased amygdala activation in response to emotional stimuli. Although top-down processes may moderate this association, available evidence is conflicting, showing the genotype influence on amygdala reactivity to be either decreased or increased during emotion regulation. Because the effects of the 5-HTTLPR polymorphism on amygdala reactivity are also conditional on self-reported life stress, differences in life stress exposure may account for this apparent discrepancy. Here, we hypothesized that self-reported life stress would moderate the relationships between genotype, cognitive appraisal, and amygdala reactivity. Forty-five healthy never-depressed subjects were presented with emotional stimuli and performed two cognitive tasks: a self-referential task and an emotion-labeling task. Life-stress exposure was measured through a semistructured interview. First, there was a genotype × condition interaction in the right amygdala: short allele carriers displayed increased amygdala activation and decreased functional connectivity with the subgenual anterior cingulate cortex in self-referential processing versus emotion labeling. Second, in line with our hypothesis, there was a genotype × condition × stress interaction in bilateral amygdala the amygdala activation during self-referential processing was negatively correlated with self-reported life stress in short allele carriers and positively in individuals homozygous for the long allele, whereas an opposite pattern was observed during emotion labeling. These results confirm that the influence of the 5-HTTLPR polymorphism on amygdala reactivity is at least partially under cognitive control. Additionally, they suggest that measuring life stress exposure is a critical step when imaging genetics.
CNRS USR 3246, Pitié-Salpêtrière Hospital, Paris, France. cedric.lemogne@egp.aphp.fr
Cédric
C
Lemogne
Philip
P
Gorwood
Claudette
C
Boni
Mathias
M
Pessiglione
Stéphane
S
Lehéricy
Philippe
P
Fossati
D000483:Alleles; D000679:Amygdala / Q000473:pathology / Q000503:physiopathology*; D001921:Brain / Q000473:pathology; D003071:Cognition / Q000502:physiology*; D004247:DNA / Q000235:genetics; D004644:Emotions / Q000502:physiology; D005260:Female; D007839:Functional Laterality / Q000502:physiology; D005838:Genotype; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D008297:Male; D009434:Neural Pathways / Q000503:physiopathology; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D050486:Serotonin Plasma Membrane Transport Proteins / Q000235:genetics*; D012938:Social Perception; D013315:Stress, Psychological / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology*; D055815:Young Adult
C493230:SLC6A4 protein, human; D050486:Serotonin Plasma Membrane Transport Proteins; D004247:DNA
Behav Neurosci. 2001 Apr;115(2):358-64
11345960
Neuroimage. 2010 Nov 15;53(3):943-51
19969089
Neuroimage. 2002 Jan;15(1):273-89
11771995
Science. 2003 Jul 18;301(5631):386-9
12869766
Rev Neurosci. 2003;14(4):303-16
14640318
Biol Psychiatry. 2004 Apr 1;55(7):733-8
15039002
Neuroimage. 2003 Jul;19(3):1233-9
12880848
Neuroimage. 2009 Sep;47(3):804-14
19446647
Neuron. 2005 Mar 3;45(5):651-60
15748841
Eur Neuropsychopharmacol. 2004 Dec;14 Suppl 5:S503-10
15550349
Am J Med Genet B Neuropsychiatr Genet. 2009 Mar 5;150B(2):271-81
18546120
Soc Cogn Affect Neurosci. 2010 Mar;5(1):1-10
19858108
Neuroimage. 2003 May;19(1):200-7
12781739
Biol Psychiatry. 2009 Feb 1;65(3):211-9
18691701
Mol Psychiatry. 2010 Jan;15(1):18-22
20029411
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
9881538
Mol Psychiatry. 2000 Jan;5(1):32-8
10673766
JAMA. 2009 Jun 17;301(23):2462-71
19531786
Psychopharmacology (Berl). 2006 Oct;188(2):213-27
16941121
Soc Cogn Affect Neurosci. 2009 Sep;4(3):305-12
19307251
J Abnorm Psychol. 1991 Nov;100(4):569-82
1757671
Biol Psychiatry. 2008 May 1;63(9):852-7
17949693
Trends Cogn Sci. 2005 May;9(5):242-9
15866151
Neuroreport. 2000 Jan 17;11(1):43-8
10683827
Soc Cogn Affect Neurosci. 2011 Sep;6(4):426-33
20519253
Nat Neurosci. 2005 Jun;8(6):828-34
15880108
Neuropsychopharmacology. 2008 Jan;33(2):418-24
17406646
Nat Neurosci. 2005 Jan;8(1):20-1
15592465
Brain Struct Funct. 2008 Sep;213(1-2):93-118
18704495
Biol Psychiatry. 2003 Mar 15;53(6):494-501
12644354
J Affect Disord. 2010 Jul;124(1-2):196-201
19945172
Arch Gen Psychiatry. 1971 Oct;25(4):340-7
5116988
Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):16033-8
17032778
Psychol Bull. 2002 Jul;128(4):638-62
12081086
Arch Gen Psychiatry. 2005 Feb;62(2):146-52
15699291
Nat Rev Neurosci. 2006 Jul;7(7):583-90
16791147
Neuroimage. 1998 Jan;7(1):30-40
9500830
J Neurosci. 2002 Aug 1;22(15):6810-8
12151561
Neuroimage. 2003 Mar;18(3):675-84
12667845
Brain Cogn. 2009 Feb;69(1):218-25
18723260
Psychopharmacology (Berl). 2005 Nov;182(4):570-8
16163530